Ann: S&P DJ Indices Announces March Quarterly Rebalance, page-215

First 215 Last

Share
Profile

Follow
YStrategy

10,917 Posts.

45

15/03/17

13:49

Post #: 23365467
Share

Originally posted by happytrader2015 ↑

wow, I looked at one post cracker referenced....https://hotcopper.com.au/posts/3627852/single
he's strongly promoting ABC learning centres dated 25/4/08 as per:

Hello Needle agree that the PE ratio is 5 and going forward 3 to 4 FY9.When I mentioned to other posters that this information was on page 24 of the presentation no one responded.I am actually an accountant so I know the numbers.I see value in ABS at the present price considering the PE ratio and the present market cap.Why would MS buy in 60% if they did not like what they see.ABS still retains 40%.

talk about a train crash, because:

Trading in ABC Learning shares was suspended in August 2008 after the company failed to release its earnings for the 2007-08 financial year.^[20]
Despite selling off assets, the company fell into receivership in November 2008 after increasing debt servicing obligations and its auditors were unable to sign off on its accounts.

On of the greatest shareholder disasters since Onetel.....what a call!!!!!!!!!!!!!!!!!

I am actually an accountant so I know the numbers...........bwahahahahahahah

game set and match I reckon.

Expand

Yes that is pretty bad advice .Maybe I changed what I was doing and things got better.One thing I haven't done is play the man and not the company.Anything I have posted has never called people names etc.

AJX Price at posting: 55.5¢ Sentiment: None Disclosure: Not Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

There are more pages in this discussion • 51 more messages in this thread...

First 215 Last

Add AJX (ASX) to my watchlist

(20min delay)
Last 1.3¢		Change 0.000(0.00%)		Mkt cap ! $20.46M

Open	High	Low	Value	Volume
1.4¢	1.4¢	1.3¢	$2.2K	157.6K

Buyers (Bids)

No.	Vol.	Price($)
1	42000	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	906200	4

View Market Depth

No.	Vol.	Price($)
1	42000	0.012
3	4058332	0.010
5	2072715	0.009
3	1186222	0.008
2	240000	0.007

Price($)	Vol.	No.
0.015	906200	4
0.016	429958	1
0.017	321118	2
0.018	115942	2
0.019	12500	1

Last trade - 14.20pm 07/10/2024 (20 minute delay)

AJX (ASX) Chart

Ann: S&P DJ Indices Announces March Quarterly Rebalance, page-215

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: S&P DJ Indices Announces March Quarterly Rebalance, page-215

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News